Pre-Asembia Checklist for Market Access Teams
INSIGHTS
Strategic and tactical insights on pharmaceutical market access topics spanning distribution, pharmacy, and access and affordability.
- Feb 13
Maintaining Medication Adherence Through Transitions of Care
- Feb 6
What to Do When Your Brand Sees a Sudden Rise in Copay Costs
- Jan 9
Revving Up for 2024: Market Access Kick-Start Resources
- Dec 5, 2023
Don’t Let Your Pharma Program Fall Behind – Optimize It Now
- Nov 7, 2023
The Key to Pharmaceutical Commercial Success
- Oct 23, 2023
Outlook on Oncology: Key Takeaways from the AVBCC 2023 Educational Summit
- Oct 12, 2023
Prior Authorization Should be a Top Concern for Pharma — Here’s Why
- Sep 19, 2023
Case Study: Fresh Approach to HUB Communications Drives 20% User Growth
- Sep 12, 2023
Webinar Archive: Pharmaceutical HUBs are Underutilized; Yours Doesn’t Have to Be
- Jun 27, 2023
How Product Acquisition Impacts Patient Support Offerings: Buy and Bill vs. Specialty Pharmacy
- Jun 20, 2023
Take the Pain out of Conversations About Coverage
- Jun 6, 2023
Market Access POV: ICER and Specialty Drug Coverage
- May 17, 2023
Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit
- May 9, 2023
How Manufacturers Can Optimize Hub Services
- Apr 5, 2023
Best Practices for Vendor Selection and Management
- Feb 6, 2023
Essential Takeaways from the 2023 ECRM Conference
- Feb 6, 2023
10 Market Access Trends to Watch for in 2023
- Dec 19, 2022
Well-designed Access and Affordability Programs can be a Key Differentiator for Pharma Companies
- Jun 23, 2022
10 Steps to Building an Integrated Pharmaceutical Launch Strategy